Orchestra BioMed Inc.

NASDAQ: OBIO · Real-Time Price · USD
2.56
-0.10 (-3.76%)
At close: Aug 15, 2025, 3:59 PM
2.57
0.19%
After-hours: Aug 15, 2025, 07:58 PM EDT

Orchestra BioMed Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-61.02M -49.12M -33.61M -23.01M
Depreciation & Amortization
308K 287K 222K 181K
Stock-Based Compensation
10.62M 7.63M 3.41M 302K
Other Working Capital
-3.73M -3.58M -451K 1.47M
Other Non-Cash Items
308K -1.61M 4.77M 217K
Deferred Income Tax
n/a n/a -3.63M 288K
Change in Working Capital
-765K -3.31M -451K 2.6M
Operating Cash Flow
-50.56M -46.13M -29.29M -19.43M
Capital Expenditures
-289K -78K -591K -274K
Cash Acquisitions
-602K n/a -29.06M -13.29M
Purchase of Investments
-72.65M -142.03M -63.53M -213K
Sales Maturities Of Investments
86.63M 152.8M 92.59M 13.5M
Other Investing Acitivies
n/a n/a -63.53M 13.29M
Investing Cash Flow
13.09M 10.69M -64.12M 13.02M
Debt Repayment
15M -10.85M 3.55M -4M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-864K 56.81M -10.13M 7K
Financial Cash Flow
29.17M 46.22M 103.26M -3.99M
Net Cash Flow
-8.3M 10.78M 9.85M -10.4M
Free Cash Flow
-50.85M -46.2M -29.88M -19.7M